AXNX insider filings

Axonics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-11-15. Screen AXNX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for AXNX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Axonics, Inc.

FiledFormInsiderReported transactionsSource
2024-11-154Woock John — EVP, Chief Mktg/Strtgy OfficerDisposition to issuer (D): 77,403 @ $71 · Disposition to issuer (D): 13,125 (derivative) @ $0 · Disposition to issuer (D): 15,555 (derivative) @ $56.81 · Disposition to issuer (D): 3,581 (derivative) @ $45.18EDGAR
2024-11-154snyderman nancy lynn MD — DirectorDisposition to issuer (D): 14,944 @ $71 · Disposition to issuer (D): 4,167 (derivative) @ $36.90 · Disposition to issuer (D): 10,000 (derivative) @ $49.96EDGAR
2024-11-154Sama Rinda — Chief Operating OfficerDisposition to issuer (D): 83,854 @ $71 · Disposition to issuer (D): 608 @ $71 · Disposition to issuer (D): 13,125 (derivative) @ $0 · Disposition to issuer (D): 11,019 (derivative) @ $56.81 · Disposition to issuer (D): 9,962 (derivative) @ $45.18 · Disposition to issuer (D): 6,294 (derivative) @ $69.37EDGAR
2024-11-154Noblett Karen — Chief Medical OfficerDisposition to issuer (D): 34,428 @ $71 · Disposition to issuer (D): 7,500 (derivative) @ $0 · Disposition to issuer (D): 2,963 (derivative) @ $56.81 · Disposition to issuer (D): 6,348 (derivative) @ $45.18 · Disposition to issuer (D): 11,998 (derivative) @ $69.37EDGAR
2024-11-154Lopez Esteban — DirectorDisposition to issuer (D): 6,600 @ $71 · Disposition to issuer (D): 10,000 (derivative) @ $11.30EDGAR
2024-11-154Keese Kari Leigh — Chief Financial OfficerDisposition to issuer (D): 40,362 @ $71 · Disposition to issuer (D): 3,125 (derivative) @ $0EDGAR
2024-11-154Demski David M — DirectorDisposition to issuer (D): 9,542 @ $71 · Disposition to issuer (D): 10,000 (derivative) @ $19.30EDGAR
2024-11-154McNamara Robert — DirectorDisposition to issuer (D): 14,861 @ $71 · Disposition to issuer (D): 10,000 (derivative) @ $36.90 · Disposition to issuer (D): 3,333 (derivative) @ $33.85 · Disposition to issuer (D): 5,000 (derivative) @ $56.20EDGAR
2024-11-154Kiernan Jane E — DirectorDisposition to issuer (D): 19,861 @ $71EDGAR
2024-11-154Ford Alfred J Jr — Chief Commercial OfficerDisposition to issuer (D): 43,450 @ $71 · Disposition to issuer (D): 11,250 (derivative) @ $0 · Disposition to issuer (D): 4,655 (derivative) @ $45.18EDGAR
2024-11-154COHEN RAYMOND W — Chief Executive Officer, DirectorDisposition to issuer (D): 292,731 @ $71 · Disposition to issuer (D): 31,125 (derivative) @ $0 · Disposition to issuer (D): 196,451 (derivative) @ $56.81 · Disposition to issuer (D): 106,776 (derivative) @ $69.37EDGAR
2024-11-154CARREL MICHAEL H — DirectorDisposition to issuer (D): 17,861 @ $71 · Disposition to issuer (D): 5,000 (derivative) @ $36.90 · Disposition to issuer (D): 10,000 (derivative) @ $50.15EDGAR
2024-11-124snyderman nancy lynn MD — DirectorGift (G): 5,000 @ $0EDGAR
2024-10-034Keese Kari Leigh — Chief Financial OfficerSale (S): 364 @ $69.40 · Sale (S): 2,597 @ $69.41EDGAR
2024-07-254COHEN RAYMOND W — Chief Executive Officer, DirectorOption exercise (M): 25,771 @ $14.19 · Option exercise (M): 78,125 @ $25.82 · Option exercise (M): 78,125 (derivative) @ $0 · Option exercise (M): 25,771 (derivative) @ $0EDGAR
2024-02-024Noblett Karen — Chief Medical OfficerOption exercise (M): 27,500 @ $0 · Sale (S): 11,288 @ $67.74 · Option exercise (M): 6,500 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2024-02-024Sama Rinda — Chief Operating OfficerOption exercise (M): 28,000 @ $0 · Option exercise (M): 10,500 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0EDGAR
2024-02-024Woock John — EVP, Chief Mktg/Strtgy OfficerOption exercise (M): 28,000 @ $0 · Sale (S): 15,899 @ $67.74 · Option exercise (M): 10,500 (derivative) @ $0 · Option exercise (M): 17,500 (derivative) @ $0EDGAR
2024-02-024Keese Kari Leigh — Chief Financial OfficerOption exercise (M): 6,167 @ $0 · Sale (S): 3,489 @ $67.74 · Option exercise (M): 2,000 (derivative) @ $0 · Option exercise (M): 4,167 (derivative) @ $0EDGAR
2024-02-024Ford Alfred J Jr — Chief Commercial OfficerOption exercise (M): 25,500 @ $0 · Sale (S): 16,615 @ $67.74 · Option exercise (M): 10,500 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2024-02-024COHEN RAYMOND W — Chief Executive Officer, DirectorOption exercise (M): 63,400 @ $0 · Sale (S): 35,161 @ $67.74 · Option exercise (M): 21,900 (derivative) @ $0 · Option exercise (M): 41,500 (derivative) @ $0EDGAR
2024-01-104Noblett Karen — Chief Medical OfficerSale (S): 15,999 @ $69.00EDGAR
2023-12-284Noblett Karen — Chief Medical OfficerSale (S): 949 @ $63 · Sale (S): 7,051 @ $63.28EDGAR
2023-10-034Dearen Danny L. — President & CFOOption exercise (M): 11,250 @ $0 · Sale (S): 7,675 @ $56.87 · Option exercise (M): 11,250 (derivative) @ $0EDGAR
2023-10-034/ADearen Danny L. — President & CFOOption exercise (M): 36,919 @ $0 · Sale (S): 17,737 @ $48.21 · Sale (S): 947 @ $49.03EDGAR
2023-08-174Ford Alfred J Jr — Chief Commercial OfficerSale (S): 14,769 @ $62.34EDGAR
2023-08-084CARREL MICHAEL H — DirectorGift (G): 500 @ $0EDGAR
2023-08-014Ford Alfred J Jr — Chief Commercial OfficerSale (S): 1,500 @ $62.01EDGAR
2023-06-284Lopez Esteban — DirectorGrant/award (A): 3,000 @ $0EDGAR
2023-06-284snyderman nancy lynn MD — DirectorGrant/award (A): 3,000 @ $0EDGAR
2023-06-284Demski David M — DirectorGrant/award (A): 3,000 @ $0EDGAR
2023-06-284McNamara Robert — DirectorGrant/award (A): 3,000 @ $0EDGAR
2023-06-284Kiernan Jane E — DirectorGrant/award (A): 3,000 @ $0EDGAR
2023-06-284CARREL MICHAEL H — DirectorGrant/award (A): 3,000 @ $0EDGAR
2023-05-314Dearen Danny L. — President & CFOSale (S): 7,699 @ $49.44 · Sale (S): 300 @ $50.14EDGAR
2023-04-254Dearen Danny L. — President & CFOOption exercise (M): 13,208 @ $14.19 · Sale (S): 10,363 @ $59.93 · Sale (S): 9,637 @ $60.50 · Option exercise (M): 13,208 (derivative) @ $0EDGAR
2023-04-244Dearen Danny L. — President & CFOOption exercise (M): 2,001 @ $14.19 · Sale (S): 2,001 @ $60.01 · Option exercise (M): 2,001 (derivative) @ $0EDGAR
2023-04-044Dearen Danny L. — President & CFOOption exercise (M): 6,633 @ $14.19 · Option exercise (M): 5,468 @ $25.82 · Option exercise (M): 2,899 @ $1.63 · Sale (S): 7,198 @ $54.83 · Sale (S): 7,802 @ $55.68 · Option exercise (M): 6,633 (derivative) @ $0 · +2 moreEDGAR
2023-02-234Sama Rinda — Chief Operating OfficerSale (S): 16,229 @ $56.18 · Sale (S): 3,700 @ $56.69 · Sale (S): 3,392 @ $56.53EDGAR
2023-02-024Sama Rinda — Chief Operating OfficerGrant/award (A): 8,750 @ $0 · Option exercise (M): 30,875 @ $0 · Sale (S): 7,791 @ $61.17 · Sale (S): 5,634 @ $61.12 · Sale (S): 741 @ $60.43 · Sale (S): 4,334 @ $61.02 · +4 moreEDGAR
2023-02-024Dearen Danny L. — President & CFOGrant/award (A): 5,000 @ $0 · Option exercise (M): 25,250 @ $0 · Sale (S): 7,791 @ $61.17 · Sale (S): 2,720 @ $61.12 · Sale (S): 474 @ $60.43 · Sale (S): 2,772 @ $61.02 · +4 moreEDGAR
2023-02-024Noblett Karen — Chief Medical OfficerGrant/award (A): 5,000 @ $0 · Option exercise (M): 10,250 @ $0 · Sale (S): 2,167 @ $61.17 · Sale (S): 1,536 @ $61.12 · Sale (S): 136 @ $60.43 · Sale (S): 795 @ $61.02 · +4 moreEDGAR
2023-02-024Woock John — EVP, Chief Mktg/Strtgy OfficerGrant/award (A): 8,750 @ $0 · Option exercise (M): 22,125 @ $0 · Sale (S): 3,389 @ $61.17 · Sale (S): 4,181 @ $61.12 · Sale (S): 581 @ $60.43 · Sale (S): 3,398 @ $61.02 · +4 moreEDGAR
2023-02-024Ford Alfred J Jr — Chief Commercial OfficerGrant/award (A): 7,500 @ $0 · Option exercise (M): 16,500 @ $0 · Sale (S): 4,235 @ $61.17 · Sale (S): 1,999 @ $61.12 · Sale (S): 541 @ $60.43 · Sale (S): 3,164 @ $61.02 · +4 moreEDGAR
2023-02-024COHEN RAYMOND W — Chief Executive Officer, DirectorGrant/award (A): 20,750 @ $0 · Option exercise (M): 61,968 @ $0 · Sale (S): 13,872 @ $61.17 · Sale (S): 9,032 @ $61.12 · Sale (S): 1,185 @ $60.43 · Sale (S): 6,932 @ $61.02 · +4 moreEDGAR
2023-01-194Woock John — EVP, Chief Mktg/Strtgy OfficerOption exercise (M): 2,793 @ $1.32 · Sale (S): 2,793 @ $67.62 · Option exercise (M): 378 @ $1.42 · Sale (S): 378 @ $67.51 · Option exercise (M): 15,000 @ $14.19 · Sale (S): 15,000 @ $67.29 · +6 moreEDGAR
2023-01-184Ford Alfred J Jr — Chief Commercial OfficerOption exercise (M): 8,509 @ $1.42 · Option exercise (M): 1,899 @ $1.63 · Option exercise (M): 9,310 @ $25.82 · Option exercise (M): 16,297 @ $14.19 · Sale (S): 15,292 @ $65.90 · Sale (S): 17,108 @ $66.69 · +5 moreEDGAR
2023-01-184COHEN RAYMOND W — Chief Executive Officer, DirectorSale (S): 18,684 @ $65.54 · Sale (S): 22,052 @ $66.27EDGAR
2022-12-154Lopez Esteban — DirectorSale (S): 2,000 @ $67.42EDGAR
2022-09-204Noblett Karen — Chief Medical OfficerOption exercise (M): 18,519 @ $14.19 · Option exercise (M): 13,964 @ $25.82 · Sale (S): 32,483 @ $78.16 · Option exercise (M): 18,519 (derivative) @ $0 · Option exercise (M): 13,964 (derivative) @ $0EDGAR

Recent 8-K events — Axonics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-11-158-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2024-11-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-08-018-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-04-308-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-04-048-K8.01 — Other EventsEDGAR
2024-03-258-K5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-02-288-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-088-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-088-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-10-308-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AXNX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs